Live Oak Investment Partners Invests $913,000 in Option Care Health, Inc. $OPCH

Live Oak Investment Partners acquired a new position in shares of Option Care Health, Inc. (NASDAQ:OPCH) in the 3rd quarter, according to the company in its most recent filing with the SEC. The fund acquired 32,883 shares of the company’s stock, valued at approximately $913,000.

Other institutional investors also recently bought and sold shares of the company. Durable Capital Partners LP grew its holdings in Option Care Health by 134.2% in the second quarter. Durable Capital Partners LP now owns 8,237,577 shares of the company’s stock worth $267,557,000 after purchasing an additional 4,720,988 shares during the last quarter. Norges Bank acquired a new stake in shares of Option Care Health in the 2nd quarter worth $69,932,000. Swedbank AB purchased a new position in Option Care Health during the 3rd quarter worth $49,455,000. Arrowstreet Capital Limited Partnership grew its stake in Option Care Health by 109.0% during the 2nd quarter. Arrowstreet Capital Limited Partnership now owns 3,410,394 shares of the company’s stock worth $110,770,000 after buying an additional 1,778,279 shares during the last quarter. Finally, Jennison Associates LLC increased its position in Option Care Health by 145.6% during the 2nd quarter. Jennison Associates LLC now owns 2,138,248 shares of the company’s stock valued at $69,450,000 after buying an additional 1,267,660 shares in the last quarter. 98.05% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several equities research analysts have weighed in on the company. Stephens raised Option Care Health to a “strong-buy” rating in a report on Thursday, December 11th. Weiss Ratings reiterated a “hold (c)” rating on shares of Option Care Health in a research note on Monday, December 29th. Truist Financial set a $40.00 target price on shares of Option Care Health in a research report on Tuesday, January 13th. JMP Securities set a $36.00 price target on shares of Option Care Health in a report on Friday, October 31st. Finally, Barrington Research lifted their price objective on shares of Option Care Health from $38.00 to $42.00 and gave the stock an “outperform” rating in a research note on Friday. One equities research analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating and three have assigned a Hold rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $37.50.

Option Care Health Price Performance

Shares of NASDAQ:OPCH opened at $36.03 on Tuesday. Option Care Health, Inc. has a twelve month low of $24.24 and a twelve month high of $36.32. The company has a current ratio of 1.56, a quick ratio of 1.05 and a debt-to-equity ratio of 0.85. The company has a market cap of $5.72 billion, a PE ratio of 28.60, a price-to-earnings-growth ratio of 2.15 and a beta of 0.80. The company’s 50 day moving average is $31.66 and its 200 day moving average is $29.54.

Insider Activity at Option Care Health

In other Option Care Health news, Director Harry M. Jansen Kraemer, Jr. acquired 38,000 shares of the business’s stock in a transaction dated Monday, November 3rd. The shares were purchased at an average price of $25.98 per share, for a total transaction of $987,240.00. Following the completion of the purchase, the director directly owned 413,390 shares of the company’s stock, valued at $10,739,872.20. The trade was a 10.12% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 0.64% of the stock is owned by company insiders.

About Option Care Health

Option Care Health (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.

Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry’s most experienced home infusion businesses.